Athanassiou, Panagiotis
Katsimbri, Pelagia
Bounas, Andreas
Gazi, Sοusana
Sarikoudis, Theodosios
Syrigou, Victoria http://orcid.org/0009-0007-8230-6626
Boumpas, Dimitrios
Georgiadis, Athanasios
Kallitsakis, Ioannis
Kampakis, Georgios
Kandyli, Anna
Kotrotsios, Anastasios
Koukli, Eftychia-Maria
Ksirogiannis, Georgios
Lagoudakis, Aristeidis
Mavragani, Clio
Mavridou, Dimitra
Merantzis, Pavlos
Natskos, Theodoros
Papadimitriou, Georgios E.
Petrou, Dimitrios
Psaltis, Dimitrios
Tsiakou, Eleni
Zakalka, Marina
Ziogas, Athanasios
,
Funding for this research was provided by:
Roche Hellas SA
Article History
Received: 1 August 2023
Revised: 8 January 2024
Accepted: 19 February 2024
First Online: 12 March 2024
Declarations
:
: The study was approved by the participating sites’ Scientific Committee prior to the initiation of any activities.
: Written consent was acquired from all study participants.
: Written consent was acquired from all participants and authors.
: • Dr Athanasiou has received speaker honoraria from Roche.• Dr Katsimbri has received honoraria and advisory board fees from Genesis Pharma, UCB, AbbVie, Amgen Hellas, Aeonorasis, Actelion, Novartis, Janssen and Pfizer• Dr Bounas has received honoraria for lectures, presentations, manuscript writing and advisory board participation from Abbvie, Aeonorasis, Amgen, Bausch Health, FARAN, Genesis Pharma, GSK, Janssen, MSD, Novartis, Pfizer and UCB.• Dr Gazi has received travel support from Jannsen, Abbvie, Pfizer, Genesis Pharma and Vianex. Advisory board fees from Boehringer Ingelheim and consultancy fees from Amgen.• Dr Sarikoudis has received travel support from Pfizer• Prof Boumpas has received honoraria for lectures, presentations and advisory board participation from Pfizer, Aeonorasis, Αstrazeneca and GSK.• V. Syrigou, is an employee of Roche Hellas S.A.